201 | Shyam Metalics IPO Analysis by Investmentz Ltd | Investmentz Ltd | May apply | IPO |
202 | Shyam Metalics IPO Analysis by Kotak Securities | Kotak Securities | Not Rated | IPO |
203 | Shyam Metalics IPO Analysis by InvestorGain.com | InvestorGain.com | May apply | IPO |
204 | Shyam Metalics IPO Analysis by Ventura Securities Limited | Ventura Securities Limited | Apply | IPO |
205 | POWERGRID InvIT IPO April 2021 Analysis by Ajcon Global Services Ltd | Ajcon Global Services Ltd | Apply | IPO |
206 | POWERGRID InvIT IPO April 2021 Analysis by Axis Capital | Axis Capital | Not Rated | IPO |
207 | POWERGRID Infra InvIT issue review | Dilip Davda | May apply | IPO |
208 | POWERGRID InvIT IPO April 2021 Analysis by GEPL Capital Ltd | GEPL Capital Ltd | Apply | IPO |
209 | POWERGRID InvIT IPO April 2021 Analysis by ICICI Direct | ICICI Direct | Not Rated | IPO |
210 | POWERGRID InvIT IPO April 2021 Analysis by IDBI Capital | IDBI Capital | Apply | IPO |
211 | POWERGRID InvIT IPO April 2021 Analysis by Kotak Securities | Kotak Securities | Not Rated | IPO |
212 | POWERGRID InvIT IPO April 2021 Analysis by Prabhudas Lilladher Pvt Ltd | Prabhudas Lilladher Pvt Ltd | Apply | IPO |
213 | Abhishek Integrations NSE SME IPO review | Dilip Davda | Avoid | IPO |
214 | Sona Comstar IPO Analysis by Angel One | Angel One | Apply | IPO |
215 | Sona Comstar IPO Analysis by Ashika Research | Ashika Research | Not Rated | IPO |
216 | Sona Comstar IPO Analysis by Axis Capital | Axis Capital | Not Rated | IPO |
217 | Sona Comstar IPO Analysis by Capital Market | Capital Market | Apply | IPO |
218 | Sona Comstar IPO Analysis by Choice Equity Broking Pvt Ltd | Choice Equity Broking Pvt Ltd | May apply | IPO |
219 | Sona BLW Precision IPO review | Dilip Davda | May apply | IPO |
220 | Sona Comstar IPO Analysis by GEPL Capital Ltd | GEPL Capital Ltd | Apply | IPO |
221 | Sona Comstar IPO Analysis by HDFC Securities Limited | HDFC Securities Limited | Not Rated | IPO |
222 | Sona Comstar IPO Analysis by Hem Securities | Hem Securities | Apply | IPO |
223 | Sona Comstar IPO Analysis by ICICI Direct | ICICI Direct | Apply | IPO |
224 | Sona Comstar IPO Analysis by Kotak Securities | Kotak Securities | Not Rated | IPO |
225 | Sona Comstar IPO Analysis by KR Choksey Securities Ltd | KR Choksey Securities Ltd | Apply | IPO |
226 | Sona Comstar IPO Analysis by Motilal Oswal | Motilal Oswal | May apply | IPO |
227 | Sona Comstar IPO Analysis by Nirmal Bang | Nirmal Bang | Apply | IPO |
228 | Sona Comstar IPO Analysis by Sharekhan Limited | Sharekhan Limited | Not Rated | IPO |
229 | Sona Comstar IPO Analysis by Ventura Securities Limited | Ventura Securities Limited | Apply | IPO |
230 | Navoday Enterprices BSE SME IPO review | Dilip Davda | Avoid | IPO |
231 | Dodla Dairy IPO Analysis by Ajcon Global Services Ltd | Ajcon Global Services Ltd | Avoid | IPO |
232 | Dodla Dairy IPO Analysis by Axis Capital | Axis Capital | Not Rated | IPO |
233 | Dodla Dairy IPO Analysis by Capital Market | Capital Market | Avoid | IPO |
234 | Dodla Dairy IPO review | Dilip Davda | May apply | IPO |
235 | Dodla Dairy IPO Analysis by Investmentz Ltd | Investmentz Ltd | May apply | IPO |
236 | KIMS IPO Analysis by Ajcon Global Services Ltd | Ajcon Global Services Ltd | Apply | IPO |
237 | KIMS IPO Analysis by Axis Capital | Axis Capital | Not Rated | IPO |
238 | KIMS IPO Analysis by Capital Market | Capital Market | Avoid | IPO |
239 | Krishna Institute (KIMS) IPO review | Dilip Davda | May apply | IPO |
240 | KIMS IPO Analysis by HDFC Securities Limited | HDFC Securities Limited | Not Rated | IPO |
241 | KIMS IPO Analysis by Investmentz Ltd | Investmentz Ltd | May apply | IPO |
242 | Adeshwar Meditex BSE SME IPO review | Dilip Davda | May apply | IPO |
243 | Times Green Energy BSE SME IPO review | Dilip Davda | Avoid | IPO |
244 | India Pesticides IPO Analysis by Ajcon Global Services Ltd | Ajcon Global Services Ltd | Apply | IPO |
245 | India Pesticides IPO Analysis by Anand Rathi | Anand Rathi | Apply | IPO |
246 | India Pesticides IPO Analysis by Angel One | Angel One | Apply | IPO |
247 | India Pesticides IPO Analysis by Arihant Capital Markets Ltd | Arihant Capital Markets Ltd | May apply | IPO |
248 | India Pesticides IPO Analysis by Ashika Research | Ashika Research | Apply | IPO |
249 | India Pesticides IPO Analysis by Axis Capital | Axis Capital | Not Rated | IPO |
250 | India Pesticides IPO Analysis by BP Equities (BP Wealth) | BP Equities (BP Wealth) | Apply | IPO |
251 | India Pesticides IPO Analysis by Canara Bank | Canara Bank | Apply | IPO |
252 | India Pesticides IPO Analysis by Capital Market | Capital Market | Avoid | IPO |
253 | India Pesticides IPO Analysis by Choice Equity Broking Pvt Ltd | Choice Equity Broking Pvt Ltd | Apply | IPO |
254 | India Pesticides IPO review | Dilip Davda | Apply | IPO |
255 | India Pesticides IPO Analysis by Hem Securities | Hem Securities | Apply | IPO |
256 | India Pesticides IPO Analysis by ICICI Direct | ICICI Direct | Apply | IPO |
257 | India Pesticides IPO Analysis by Investmentz Ltd | Investmentz Ltd | May apply | IPO |
258 | India Pesticides IPO Analysis by Motilal Oswal | Motilal Oswal | Apply | IPO |
259 | India Pesticides IPO Analysis by Prabhudas Lilladher Pvt Ltd | Prabhudas Lilladher Pvt Ltd | Apply | IPO |
260 | India Pesticides IPO Analysis by Reliance Securities | Reliance Securities | Apply | IPO |
261 | India Pesticides IPO Analysis by Religare Broking Limited | Religare Broking Limited | Not Rated | IPO |
262 | India Pesticides IPO Analysis by StockEdge | StockEdge | Not Rated | IPO |
263 | India Pesticides IPO Analysis by Ventura Securities Limited | Ventura Securities Limited | Not Rated | IPO |
264 | Focus Business BSE SME IPO review | Dilip Davda | May apply | IPO |
265 | Walpar Nutritions NSE SME IPO review | Dilip Davda | Avoid | IPO |
266 | G R Infraprojects IPO Analysis by Ajcon Global Services Ltd | Ajcon Global Services Ltd | Apply | IPO |
267 | G R Infraprojects IPO Analysis by Angel One | Angel One | Apply | IPO |
268 | G R Infraprojects IPO Analysis by Arun Kejriwal | Arun Kejriwal | Apply | IPO |
269 | G R Infraprojects IPO Analysis by Ashika Research | Ashika Research | Apply | IPO |
270 | G R Infraprojects IPO Analysis by Axis Capital | Axis Capital | Not Rated | IPO |
271 | G R Infraprojects IPO Analysis by BP Equities (BP Wealth) | BP Equities (BP Wealth) | Apply | IPO |
272 | G R Infraprojects IPO Analysis by Canara Bank | Canara Bank | Apply | IPO |
273 | G R Infraprojects IPO Analysis by Capital Market | Capital Market | Apply | IPO |
274 | G R Infraprojects IPO Analysis by Choice Equity Broking Pvt Ltd | Choice Equity Broking Pvt Ltd | Apply | IPO |
275 | G R Infra IPO review | Dilip Davda | May apply | IPO |
276 | G R Infraprojects IPO Analysis by GEPL Capital Ltd | GEPL Capital Ltd | Apply | IPO |
277 | G R Infraprojects IPO Analysis by HDFC Securities Limited | HDFC Securities Limited | Not Rated | IPO |
278 | G R Infraprojects IPO Analysis by Hem Securities | Hem Securities | Apply | IPO |
279 | G R Infraprojects IPO Analysis by ICICI Direct | ICICI Direct | Not Rated | IPO |
280 | G R Infraprojects IPO Analysis by IDBI Capital | IDBI Capital | Apply | IPO |
281 | G R Infraprojects IPO Analysis by Investmentz Ltd | Investmentz Ltd | May apply | IPO |
282 | G R Infraprojects IPO Analysis by JM Financial Institutional Securities | JM Financial Institutional Securities | Not Rated | IPO |
283 | G R Infraprojects IPO Analysis by Nirmal Bang | Nirmal Bang | Apply | IPO |
284 | G R Infraprojects IPO Analysis by Phillip Capital | Phillip Capital | Apply | IPO |
285 | G R Infraprojects IPO Analysis by Prabhudas Lilladher Pvt Ltd | Prabhudas Lilladher Pvt Ltd | Apply | IPO |
286 | G R Infraprojects IPO Analysis by Reliance Securities | Reliance Securities | Apply | IPO |
287 | G R Infraprojects IPO Analysis by Religare Broking Limited | Religare Broking Limited | Not Rated | IPO |
288 | G R Infraprojects IPO Analysis by Sharekhan Limited | Sharekhan Limited | Not Rated | IPO |
289 | G R Infraprojects IPO Analysis by Ventura Securities Limited | Ventura Securities Limited | Not Rated | IPO |
290 | Clean Science IPO Analysis by Aditya Birla Ltd | Aditya Birla Ltd | Apply | IPO |
291 | Clean Science IPO Analysis by Angel One | Angel One | Apply | IPO |
292 | Clean Science IPO Analysis by Ashika Research | Ashika Research | Apply | IPO |
293 | Clean Science IPO Analysis by Axis Capital | Axis Capital | Not Rated | IPO |
294 | Clean Science IPO Analysis by BP Equities (BP Wealth) | BP Equities (BP Wealth) | Apply | IPO |
295 | Clean Science IPO Analysis by Canara Bank | Canara Bank | Apply | IPO |
296 | Clean Science IPO Analysis by Capital Market | Capital Market | Apply | IPO |
297 | Clean Science IPO review | Dilip Davda | May apply | IPO |
298 | Clean Science IPO Analysis by GEPL Capital Ltd | GEPL Capital Ltd | Apply | IPO |
299 | Clean Science IPO Analysis by HDFC Securities Limited | HDFC Securities Limited | Neutral | IPO |
300 | Clean Science IPO Analysis by Hem Securities | Hem Securities | Apply | IPO |
301 | Clean Science IPO Analysis by ICICI Direct | ICICI Direct | Apply | IPO |
302 | Clean Science IPO Analysis by IIFL Securities | IIFL Securities | Apply | IPO |
303 | Clean Science IPO Analysis by Investmentz Ltd | Investmentz Ltd | Apply | IPO |
304 | Clean Science IPO Analysis by JM Financial Institutional Securities | JM Financial Institutional Securities | Not Rated | IPO |
305 | Clean Science IPO Analysis by LKP Securities Ltd | LKP Securities Ltd | Apply | IPO |
306 | Clean Science IPO Analysis by Reliance Securities | Reliance Securities | Apply | IPO |
307 | Clean Science IPO Analysis by Sharekhan Limited | Sharekhan Limited | Not Rated | IPO |
308 | Clean Science IPO Analysis by Sushil Finance Ltd | Sushil Finance Ltd | Neutral | IPO |
309 | Clean Science IPO Analysis by Ventura Securities Limited | Ventura Securities Limited | Apply | IPO |
310 | Glenmark Life Sciences IPO Analysis by Anand Rathi | Anand Rathi | Apply | IPO |
311 | Glenmark Life Sciences IPO Analysis by Ashika Research | Ashika Research | Apply | IPO |
312 | Glenmark Life Sciences IPO Analysis by Axis Capital | Axis Capital | Neutral | IPO |
313 | Glenmark Life Sciences IPO Analysis by Capital Market | Capital Market | May apply | IPO |
314 | Glenmark Life Sciences IPO Analysis by Choice Equity Broking Pvt Ltd | Choice Equity Broking Pvt Ltd | Apply | IPO |
315 | Glenmark Life IPO review | Dilip Davda | May apply | IPO |
316 | Glenmark Life Sciences IPO Analysis by Dolat Analysis and Research | Dolat Analysis and Research | Apply | IPO |
317 | Glenmark Life Sciences IPO Analysis by GEPL Capital Ltd | GEPL Capital Ltd | Apply | IPO |
318 | Glenmark Life Sciences IPO Analysis by HDFC Securities Limited | HDFC Securities Limited | Neutral | IPO |
319 | Glenmark Life Sciences IPO Analysis by ICICI Direct | ICICI Direct | Apply | IPO |
320 | Glenmark Life Sciences IPO Analysis by Investmentz Ltd | Investmentz Ltd | Apply | IPO |
321 | Glenmark Life Sciences IPO Analysis by SMC Global | SMC Global | May apply | IPO |
322 | Glenmark Life Sciences IPO Analysis by Sushil Finance Ltd | Sushil Finance Ltd | Apply | IPO |
323 | Glenmark Life Sciences IPO Analysis by InvestorGain.com | InvestorGain.com | Apply | IPO |
324 | Glenmark Life Sciences IPO Analysis by Ventura Securities Limited | Ventura Securities Limited | Apply | IPO |
325 | AA Plus BSE SME IPO review | Dilip Davda | Avoid | IPO |
326 | Zomato IPO Analysis by Ambit Capital Pvt Ltd | Ambit Capital Pvt Ltd | Neutral | IPO |
327 | Zomato IPO Analysis by Axis Capital | Axis Capital | Neutral | IPO |
328 | Zomato IPO Analysis by Capital Market | Capital Market | May apply | IPO |
329 | Zomato IPO Analysis by Choice Equity Broking Pvt Ltd | Choice Equity Broking Pvt Ltd | May apply | IPO |
330 | Zomato IPO review | Dilip Davda | Avoid | IPO |
331 | Zomato IPO Analysis by GEPL Capital Ltd | GEPL Capital Ltd | Apply | IPO |
332 | Zomato IPO Analysis by ICICI Securities | ICICI Securities | Neutral | IPO |
333 | Zomato IPO Analysis by KR Choksey Securities Ltd | KR Choksey Securities Ltd | Apply | IPO |
334 | Zomato IPO Analysis by Religare Broking Limited | Religare Broking Limited | Neutral | IPO |
335 | Zomato IPO Analysis by Sharekhan Limited | Sharekhan Limited | Neutral | IPO |
336 | Zomato IPO Analysis by Ventura Securities Limited | Ventura Securities Limited | Apply | IPO |
337 | Tatva Chintan Pharma IPO Analysis by Axis Capital | Axis Capital | Neutral | IPO |
338 | Tatva Chintan Pharma IPO Analysis by Capital Market | Capital Market | May apply | IPO |
339 | Tatva Chintan IPO review | Dilip Davda | Apply | IPO |
340 | Tatva Chintan Pharma IPO Analysis by Investmentz Ltd | Investmentz Ltd | Apply | IPO |
341 | Tatva Chintan Pharma IPO Analysis by KR Choksey Securities Ltd | KR Choksey Securities Ltd | Apply | IPO |
342 | Tatva Chintan Pharma IPO Analysis by Motilal Oswal | Motilal Oswal | Apply | IPO |
343 | Tatva Chintan Pharma IPO Analysis by Reliance Securities | Reliance Securities | Apply | IPO |
344 | Tatva Chintan Pharma IPO Analysis by Sharekhan Limited | Sharekhan Limited | Neutral | IPO |
345 | Tatva Chintan Pharma IPO Analysis by InvestorGain.com | InvestorGain.com | Apply | IPO |
346 | Tatva Chintan Pharma IPO Analysis by Ventura Securities Limited | Ventura Securities Limited | Apply | IPO |
347 | Paytm IPO Analysis by Anand Rathi | Anand Rathi | Apply | IPO |
348 | Paytm IPO Analysis by Arihant Capital Markets Ltd | Arihant Capital Markets Ltd | Apply | IPO |
349 | Paytm IPO Analysis by Ashika Research | Ashika Research | Neutral | IPO |
350 | Paytm IPO Analysis by Axis Capital | Axis Capital | Neutral | IPO |
351 | Paytm IPO Analysis by Axis Securities Limited | Axis Securities Limited | Neutral | IPO |
352 | Paytm IPO Analysis by Canara Bank | Canara Bank | Apply | IPO |
353 | One 97 Communications Limited IPO Analysis by Capital Market | Capital Market | Neutral | IPO |
354 | One 97 Commu (PayTM) IPO review | Dilip Davda | May apply | IPO |
355 | Paytm IPO Analysis by ICICI Direct | ICICI Direct | Neutral | IPO |
356 | Paytm IPO Pre-Listing Analysis by Macquarie Research | Macquarie Research | Avoid | IPO |
357 | Paytm IPO Analysis by Multi-Act Equity Consultancy Pvt Ltd | Multi-Act Equity Consultancy Pvt Ltd | Neutral | IPO |
358 | Paytm IPO Analysis by Reliance Securities | Reliance Securities | Apply | IPO |
359 | Paytm IPO Analysis by Religare Broking Limited | Religare Broking Limited | Neutral | IPO |
360 | Paytm IPO Analysis by InvestorGain.com | InvestorGain.com | Apply | IPO |
361 | Rolex Rings IPO Analysis by Axis Capital | Axis Capital | Neutral | IPO |
362 | Rolex Rings IPO Analysis by Capital Market | Capital Market | May apply | IPO |
363 | Rolex Rings IPO review | Dilip Davda | Apply | IPO |
364 | Rolex Rings IPO Analysis by Hem Securities | Hem Securities | Apply | IPO |
365 | Rolex Rings IPO Analysis by ICICI Direct | ICICI Direct | Apply | IPO |
366 | Rolex Rings IPO Analysis by KR Choksey Securities Ltd | KR Choksey Securities Ltd | Apply | IPO |
367 | Rolex Rings IPO Analysis by Reliance Securities | Reliance Securities | Apply | IPO |
368 | Rolex Rings IPO Analysis by Ventura Securities Limited | Ventura Securities Limited | Apply | IPO |
369 | Rex Pipes NSE SME IPO review | Dilip Davda | May apply | IPO |
370 | Gretex Corp BSE SME IPO review | Dilip Davda | Avoid | IPO |
371 | Network People NSE SME IPO review | Dilip Davda | May apply | IPO |
372 | Nuvoco IPO Analysis by Angel One | Angel One | Apply | IPO |
373 | Nuvoco IPO Analysis by Arun Kejriwal | Arun Kejriwal | May apply | IPO |
374 | Nuvoco IPO Analysis by Axis Capital | Axis Capital | Neutral | IPO |
375 | Nuvoco IPO Analysis by Canara Bank | Canara Bank | Apply | IPO |
376 | Nuvoco IPO Analysis by Capital Market | Capital Market | Avoid | IPO |
377 | Nuvoco Vistas IPO review | Dilip Davda | May apply | IPO |
378 | Nuvoco IPO Analysis by Edelweiss Broking Ltd | Edelweiss Broking Ltd | Neutral | IPO |
379 | Nuvoco IPO Analysis by HDFC Securities Limited | HDFC Securities Limited | Neutral | IPO |
380 | Nuvoco IPO Analysis by Hem Securities | Hem Securities | Apply | IPO |
381 | Nuvoco IPO Analysis by ICICI Direct | ICICI Direct | Neutral | IPO |
382 | Nuvoco IPO Analysis by IDBI Capital | IDBI Capital | Apply | IPO |
383 | Nuvoco IPO Analysis by Investmentz Ltd | Investmentz Ltd | Apply | IPO |
384 | Nuvoco IPO Analysis by KR Choksey Securities Ltd | KR Choksey Securities Ltd | Apply | IPO |
385 | Nuvoco IPO Analysis by InvestorGain.com | InvestorGain.com | Avoid | IPO |
386 | Exxaro Tiles IPO Analysis by Arihant Capital Markets Ltd | Arihant Capital Markets Ltd | Apply | IPO |
387 | Exxaro Tiles IPO Analysis by Arun Kejriwal | Arun Kejriwal | May apply | IPO |
388 | Exxaro Tiles IPO Analysis by AUM Capital Ltd | AUM Capital Ltd | Neutral | IPO |
389 | Exxaro Tiles IPO Analysis by Canara Bank | Canara Bank | Apply | IPO |
390 | Exxaro Tiles IPO Analysis by Capital Market | Capital Market | May apply | IPO |
391 | Exxaro Tiles IPO review | Dilip Davda | May apply | IPO |
392 | Exxaro Tiles IPO Analysis by Hem Securities | Hem Securities | Apply | IPO |
393 | Exxaro Tiles IPO Analysis by JM Financial Institutional Securities | JM Financial Institutional Securities | Neutral | IPO |
394 | Exxaro Tiles IPO Analysis by Reliance Securities | Reliance Securities | Neutral | IPO |
395 | Exxaro Tiles IPO Analysis by SMC Global | SMC Global | Apply | IPO |
396 | Windlas Biotech IPO Analysis by Capital Market | Capital Market | Avoid | IPO |
397 | Windlas Bio IPO review | Dilip Davda | May apply | IPO |
398 | Windlas Biotech IPO Analysis by JM Financial Institutional Securities | JM Financial Institutional Securities | Neutral | IPO |
399 | Windlas Biotech IPO Analysis by InvestorGain.com | InvestorGain.com | Apply | IPO |
400 | Devyani International IPO Analysis by Angel One | Angel One | Apply | IPO |
First Prev 2 of 4 Next Last |